Profusa, Inc. financial data

Symbol
PFSA on Nasdaq, NVACW on OTC
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 19 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 4.7% % -65%
Debt-to-equity -33% % -630%
Return On Equity 29% % 388%
Return On Assets -1029% % -1303%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 65,680,958 shares 1017%
Common Stock, Shares, Outstanding 41,731,496 shares 703%
Entity Public Float $68,215,988 USD
Common Stock, Value, Issued $4,000 USD 671%
Weighted Average Number of Shares Outstanding, Basic 31,731,118 shares 1537%
Weighted Average Number of Shares Outstanding, Diluted 31,731,118 shares 1537%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $75,000 USD
Research and Development Expense $722,000 USD 76%
General and Administrative Expense $20,987,000 USD 2636%
Operating Income (Loss) $22,783,732 USD -896%
Nonoperating Income (Expense) $13,664,138 USD -1119%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $16,752,870 USD -1237%
Income Tax Expense (Benefit) $57,771 USD -40%
Net Income (Loss) Attributable to Parent $28,989,619 USD -330%
Earnings Per Share, Basic -2 USD/shares -61%
Earnings Per Share, Diluted -2 USD/shares -61%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,009,000 USD 564440%
Assets, Current $4,195,000 USD 515%
Other Assets, Noncurrent $55,000 USD
Assets $4,250,000 USD -52%
Accounts Payable, Current $6,982,000 USD
Accrued Liabilities, Current $7,848,000 USD 980%
Liabilities, Current $23,540,000 USD 356%
Liabilities $38,210,000 USD 557%
Retained Earnings (Accumulated Deficit) $152,214,000 USD -2841%
Stockholders' Equity Attributable to Parent $33,960,000 USD 71%
Liabilities and Equity $4,250,000 USD -52%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $362,441 USD -29%
Net Cash Provided by (Used in) Financing Activities $6,125,672 USD -169%
Net Cash Provided by (Used in) Investing Activities $6,490,359 USD 154%
Common Stock, Shares Authorized 600,000,000 shares 500%
Common Stock, Shares, Issued 41,731,496 shares 703%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,009,000 USD 2049%
Deferred Tax Assets, Valuation Allowance $694,480 USD 59%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $694,480 USD 64%
Deferred Income Tax Expense (Benefit) $13,661 USD 62%
Deferred Tax Assets, Operating Loss Carryforwards $694,480 USD 59%
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Additional Paid in Capital $118,250,000 USD
Share-based Payment Arrangement, Expense $617,000 USD 5042%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%